Literature DB >> 30967264

Decreased expression of NEDD4L contributes to NSCLC progression and metastasis.

Xuming Wang1, Jin Duan2, Weiping Fu1, Zhaowu Yin3, Jianing Sheng3, Zhuyun Lei4, Han Wang5.   

Abstract

Recent evidence indicated that neural precursor cell expressed, developmentally down-regulated 4-like (NEDD4L) has a critical role in the regulation of cellular processes such as apoptosis, transport and metastasis, and is downregulated in several types of cancers. However, the role of NEDD4L in non-small cell lung cancer (NSCLC) has not been fully elucidated. In this study, we demonstrated that NEDD4L was downregulated in NSCLCs. This downregulation correlated with lymph node invasion, advanced stage and poor survival. In vitro experiments revealed that NEDD4L significantly suppressed cell proliferation, migration and invasion abilities. Further in vivo assay demonstrated that knocking down of NEDD4L enhanced the tumor metastasis of NSCLC cells. Moreover, we found that Polycomb group protein enhancer of zeste homologue 2 (EZH2) mediated H3K27 methylation was involved in the downregulation of NEDD4L. Knocking down of EZH2 restored the expression of NEDD4L. Further examined by luciferase reporter assay indicated the EZH2 regulated the transcription activity of NEDD4L. In clinical samples, EZH2 was inversely correlated with NEDD4L expression. In summary, NEDD4L acted as a tumor suppressor gene in NSCLC and targeting EZH2 could upregulate NEDD4L expression, which might serve as a novel approach for NSCLC.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  EZH2; NEDD4L; NSCLC; Prognosis

Mesh:

Substances:

Year:  2019        PMID: 30967264     DOI: 10.1016/j.bbrc.2019.04.001

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival.

Authors:  Sen Yang; Dongfang Tang; Yu C Zhao; Hongliang Liu; Sheng Luo; Thomas E Stinchcombe; Carolyn Glass; Li Su; Sipeng Shen; David C Christiani; Qiming Wang; Qingyi Wei
Journal:  Int J Cancer       Date:  2019-12-19       Impact factor: 7.396

2.  NEDD4L suppresses PD-L1 expression and enhances anti-tumor immune response in A549 cells.

Authors:  Bin Zhong; Jie Zheng; Huilan Wen; Xinhui Liao; Xingxiang Chen; Yunwei Rao; Ping Yuan
Journal:  Genes Genomics       Date:  2022-03-30       Impact factor: 2.164

3.  Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway.

Authors:  Yi Zeng; Zhijian Feng; Yunjuan Liao; Ming Yang; Yihua Bai; Zhenkun He
Journal:  Cell Cycle       Date:  2020-12-14       Impact factor: 4.534

4.  Ubiquitination Destabilizes Protein Sphingosine Kinase 2 to Regulate Glioma Malignancy.

Authors:  Hongliang Wang; Bing Zhao; Erbao Bian; Gang Zong; Jie He; Yuyang Wang; Chunchun Ma; Jinghai Wan
Journal:  Front Cell Neurosci       Date:  2021-07-07       Impact factor: 5.505

5.  Construction of prognostic predictor by comprehensive analyzing alternative splicing events for colon adenocarcinoma.

Authors:  Yaqi Qu; Yujia Chen; Le Zhang; Lifei Tian
Journal:  World J Surg Oncol       Date:  2020-09-03       Impact factor: 2.754

6.  Downregulation of NEDD4L by EGFR signaling promotes the development of lung adenocarcinoma.

Authors:  Guoyin Li; Zewen Song; Changjing Wu; XiaoYan Li; Liping Zhao; Binghua Tong; Zhenni Guo; Meiqing Sun; Jin Zhao; Huina Zhang; Lintao Jia; Shengqing Li; Lei Wang
Journal:  J Transl Med       Date:  2022-01-28       Impact factor: 5.531

Review 7.  The regulatory roles of the E3 ubiquitin ligase NEDD4 family in DNA damage response.

Authors:  Xinxin Lu; Haiqi Xu; Jiaqi Xu; Saien Lu; Shilong You; Xinyue Huang; Naijin Zhang; Lijun Zhang
Journal:  Front Physiol       Date:  2022-08-26       Impact factor: 4.755

8.  Construction and Analysis of Survival-Associated Competing Endogenous RNA Network in Lung Adenocarcinoma.

Authors:  Lixian Chen; Zhonglu Ren; Yongming Cai
Journal:  Biomed Res Int       Date:  2021-02-11       Impact factor: 3.411

9.  Identification of Candidate lncRNA and Pseudogene Biomarkers Associated with Carbon-Nanotube-Induced Malignant Transformation of Lung Cells and Prediction of Potential Preventive Drugs.

Authors:  Guangtao Chang; Dongli Xie; Jianchen Hu; Tong Wu; Kangli Cao; Xiaogang Luo
Journal:  Int J Environ Res Public Health       Date:  2022-03-02       Impact factor: 3.390

10.  ALCAP2 inhibits lung adenocarcinoma cell proliferation, migration and invasion via the ubiquitination of β-catenin by upregulating the E3 ligase NEDD4L.

Authors:  Weijie Zhang; Ruochen Zhang; Yuanyuan Zeng; Yue Li; Yikun Chen; Jieqi Zhou; Yang Zhang; Anqi Wang; Jianjie Zhu; Zeyi Liu; Zhaowei Yan; Jian-An Huang
Journal:  Cell Death Dis       Date:  2021-07-31       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.